CFM
HALO icon

Catalyst Funds Management’s Halozyme HALO Stock Holding History

Catalyst Funds Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$207K Buy
+2,650
New +$181K 0.01% 584
2025
Q4 		– Sell
-43,800
Closed -$3.21M – 434
2025
Q3 		$3.21M Buy
43,800
+3,500
+9% +$232K 0.49% 40
2025
Q2 		$2.1M Buy
+40,300
New +$2.29M 0.58% 38
2024
Q3 		– Sell
-3,600
Closed -$188K – 1420
2024
Q2 		$188K Buy
3,600
+3,200
+800% +$140K 0.05% 211
2024
Q1 		$16.3K Buy
+400
New +$15K ﹤0.01% 804

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Catalyst Funds Management's HALO Position: Q2 2026 in Review

Catalyst Funds Management opened a new position in Halozyme (HALO) in Q2 2026: 2,650 shares worth $207K. The stake represents 0.01% of the portfolio and ranks #584 among its holdings. This is a return to the name: Catalyst Funds Management previously reported a position in HALO as recently as Q3 2025.

Catalyst Funds Management first reported a position in HALO in Q1 2024 and has held it in 5 quarters since. The position peaked at $3.21M in Q3 2025. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Catalyst Funds Management held 2,650 shares of Halozyme worth $207K as of Q2 2026.
  • Halozyme was a new Catalyst Funds Management position in Q2 2026.
  • Halozyme made up 0.01% of Catalyst Funds Management's portfolio in Q2 2026, its #584 holding.
  • Catalyst Funds Management first reported a position in Halozyme in Q1 2024 and has held it in 5 quarters since.
  • Catalyst Funds Management's Halozyme position peaked at $3.21M in Q3 2025.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Catalyst Funds Management's 13F filing for Q2 2026, filed 10 Aug 2026.